Meetings:

Federal Register: August 23, 2010 (Volume 75, Number 162)

Notices

Page 51827

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr23au10-82

Page 51827

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

Office of the Director, National Institutes of Health; Notice of

Meeting

Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the

Recombinant DNA Advisory Committee.

The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.

Name of Committee: Recombinant DNA Advisory Committee.

Date: September 15-17, 2010.

Time: September 15, 2010, 1:30 p.m. to 5:30 p.m.

Agenda: The Office of Biotechnology Activities (OBA) and NIH

Recombinant DNA Advisory Committee will review and discuss selected human gene transfer protocols as well as related data management activities. Please check the meeting agenda at http:// oba.od.nih.gov/rdna_rac/rac_meetings.html for more information.

Place: Hilton Washington/Rockville, 1750 Rockville Pike,

Executive Meeting Center, Rockville, MD 20852.

Time: September 16, 2010, 8 a.m. to 5:30 p.m.

Agenda: The Recombinant DNA Advisory Committee will review and discuss selected human gene transfer protocols, have a discussion of ethical considerations in review of pediatric protocols, and discuss related data management activities. Please check the meeting agenda at http://oba.od.nih.gov/rdna_rac/rac_meetings.html for more information.

Place: Hilton Washington/Rockville, 1750 Rockville Pike,

Executive Meeting Center, Rockville, MD 20852.

Time: September 17, 2010, 8 a.m. to 1 p.m.

Agenda: The Recombinant DNA Advisory Committee will review and discuss selected human gene transfer protocols, have a discussion of ethical considerations in review of pediatric protocols, and discuss related data management activities. Please check the meeting agenda at http://oba.od.nih.gov/rdna_rac/rac_meetings.html for more information.

Place: Hilton Washington/Rockville, 1750 Rockville Pike,

Executive Meeting Center, Rockville, MD 20852.

Contact Person: Chezelle George, Office of Biotechnology

Activities, Office of Science Policy/OD, National Institutes of

Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892. 301-496- 9838. georgec@od.nih.gov.

Information is also available on the Institute's/Center's home page: http://oba.od.nih.gov/rdna/rdna.html, where an agenda and any additional information for the meeting will be posted when available.

OMB's ``Mandatory Information Requirements for Federal

Assistance Program Announcements'' (45 FR 39592, June 11, 1980) requires a statement concerning the official government programs contained in the Catalog of Federal Domestic Assistance. Normally

NIH lists in its announcements the number and title of affected individual programs for the guidance of the public. Because the guidance in this notice covers virtually every NIH and Federal research program in which DNA recombinant molecule techniques could be used, it has been determined not to be cost effective or in the public interest to attempt to list these programs. Such a list would likely require several additional pages. In addition, NIH could not be certain that every Federal program would be included as many

Federal agencies, as well as private organizations, both national and international, have elected to follow the NIH Guidelines. In lieu of the individual program listing, NIH invites readers to direct questions to the information address above about whether individual programs listed in the Catalog of Federal Domestic

Assistance are affected.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14,

Intramural Research Training Award; 93.22, Clinical Research Loan

Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39,

Academic Research Enhancement Award; 93.936, NIH Acquired

Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,

Undergraduate Scholarship Program for Individuals from Disadvantaged

Backgrounds, National Institutes of Health, HHS)

Dated: August 17, 2010.

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.

FR Doc. 2010-20861 Filed 8-20-10; 8:45 am

BILLING CODE 4140-01-P